Changing views of the role of matrix metalloproteinases in metastasis

Journal of the National Cancer Institute

Volumn 89, Issue 17, 1997, Pages 1260-1270

  Chambers, Ann F ^a,c   Matrisian, Lynn M ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE;

ANGIOGENESIS; DISEASE ASSOCIATION; ENZYME INHIBITION; EXTRAVASATION; GROWTH REGULATION; HUMAN; IMMUNE RESPONSE; METASTASIS; PROTEIN DOMAIN; REVIEW; TUMOR GROWTH;

EID: 0030806173     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.17.1260     Document Type: Review

References (127)

1. Liotta LA. Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991:51 (18 Suppl):5054s-9s.
2. Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993;24:209-18.
3. DeClerck YA, Imren S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur J Cancer 1994;30A:2170-80.
4. Jiang WG, Puntis MC, Hallett MB. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 1994;81: 1576-90.
5. MacDougall JR, Mutrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995;14:351-62.
6. Powell WC, Matrisian LM. Complex roles of matrix metalloproteinases in tumor progression. In: Gunthert U, Birchmeier W, editors. Attempts to understand metastasis formation I: metastasis-related molecules. Berlin: Springer-Verlag, 1996:1-21.
7. Denhardt DT. On the paradoxical ability of TIMPs either to inhibit or to promote the development and progression of the malignant phenotype. In: Hawkes SP, Edwards DR, Khokha R, editors. Inhibitors of metalloproteinases in development and disease. Lausanne: Harwood Academic Publisher. In press.
8. Liotta LA, Stetler-Stevenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott. 1993:134-49.
9. Tarin D. Cancer metastasis. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, editors. Clinical oncology. Churchill Livingston, 1995: 118-32.
10. Nicolson GL. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr Opin Oncol 1991;3:75-92.
11. Fidler IJ. 7th Jan Waldenstrom Lecture. The biology of human cancer metastasis. Acta Oncol 1991;30:668-75.
12. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, editors. The molecular basis of cancer. Philadelphia: Saunders, 1995:206-32.
13. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
14. Butler TP. Gullino PM. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975;35:512-6.
15. Tarin D. Vass AC. Kettlewell MG. Price JE. Absence of metastatic sequelae during long-term treatment of malignant ascites by peritoneovenous shunting. A clinico-pathological report. Invasion Metastasis 1984: 4:1-12.
16. 1251-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970;45:773-82.
17. Mayhew E. Glaves D. Quantitation of tumorigenic disseminating and arrested cancer cells. Br J Cancer 1984;50:159-66.
18. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990;54:159-211.
19. Talmadge JE. Wolman SR. Fidler IJ. Evidence for the clonal origin of spontaneous metastases. Science 1982;217:361-3.
20. Talmadge JE, Zbar B. Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by Southern hybridization. J Natl Cancer Inst 1987;78:315-20.
21. R B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo. Clin Exp Metastasis 1988;6:171-82.
22. Weinberg RA. Prospects for cancer genetics. Cancer Surv 1997;25:3-12.
23. Bishop JM. Molecular themes in oncogenesis. Cell 1991:64:235-48.
24. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
25. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
26. Chambers AF. DNA transfection, genetic instability, and metastasis. In: Liotta LA, editor. Influence of tumor development on the host, cancer growth and progression. Dordrecht: Kluwer Academic Publishers, Vol. III, Kaiser HE, series editor, 1989:97-102.
27. Chambers AF, Tuck AB. Ras-responsive genes and tumor metastasis. Crit Rev Oncog 1993;4:95-114.
28. Tuck AB, Wilson SM, Khokha R, Chambers AF. Different patterns of gene expression in ras-resistant and ras-sensitive cells. J Natl Cancer Inst 1991;83:485-91.
29. MacDonald NJ, de la Rosa A, Steeg PS. The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 1995;31A: 1096-100.
30. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-6.
31. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996;88:1731-7.
32. Fidler IJ, Radinsky R. Search for genes that suppress cancer metastasis [editorial]. J Natl Cancer Inst 1996;88:1700-3.
33. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, BirkedalHansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
34. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 1962;48:1014-22.
35. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983;49:140-7.
36. Liotta LA, Thorgeirsson UP, Garbisa S. Role of collagenases in tumor cell invasion. Cancer Metastasis Rev 1982;1:277-88.
37. Pauli BU, Schwartz DE, Thonar EJA, Kuettner KE. Tumor invasion and host extracellular matrix. Cancer Metastasis Rev 1983:2:129-52.
38. Woolley DE. Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev 1984;3:361-72.
39. Duffy MJ. Do proteases play a role in cancer invasion and metastasis? Eur J Cancer Clin Oncol 1987;23:583-9.
40. Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 1986;47: 487-98.
41. Liotta LA, Kleinerman J, Catanzaro P, Rynbrandt D. Degradation of basement membrane by murine tumor cells. J Natl Cancer Inst 1977;58: 1427-31.
42. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM. Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-8.
43. Salo T, Liotta LA, Keski-Oja J, Turpeenniemi-Hujanen T, Tryggvason K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - role in metastasis. Int J Cancer 1982;30:669-73.
44. Brunner N, Pyke C, Hansen CH, Romer J, Grondahl-Hansen J, Dano K. Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treat Res 1994;71:299-309.
45. Sloane BF, Moin K, Lah TT. Regulation of lysosomal endopeptidases in malignant neoplasia. In: Pretlow TG, II. Pretlow TP, editors. Biochemical and molecular aspects of selected cancers. Vol. 2. San Diego: Academic Press, 1994:411-66.
46. Matrisian LM. Glaichenhaus N. Gesnel MC. Breathnach R. Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 1985;4:1435-40.
47. Matrisian LM. Bowden GT. Krieg P. Furstenberger G. Briand JP. Leroy P. el al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A 1986:83:9413-7.
48. Goldberg GI. Wilhelm SM. Kronberger A. Bauer EA. Grant GA. Eisen AZ. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986;261:6600-5.
49. Whitham SE, Murphy G, Angel P, Rahmsdorf HJ, Smith BJ, Lyons A, et al. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J 1986;240:913-6.
50. Ray JM, Stetler-Stevenson WG. The role of metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994;7:2062-72.
51. Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa f, el al. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 1996;56:1654-9.
52. Khokha R, Martin DC, Fata JE. Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors. Cancer Metastasis Rev 1995;14:97-111.
53. Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 1988;48:5539-45.
54. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989;244:947-50.
55. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990;82:589-95.
56. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, et al. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 1993;53:1397-402.
57. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 1994;86: 299-304.
58. Watanabe M, Takahashi Y, Ohta T, Mai M, Sasaki T, Seiki M. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer 1996;77:1676-80.
59. Chirivi RG, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, et al. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 1994;58:460-4.
60. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995;55:3629-33.
61. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 1996;56:2815-22.
62. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994;54:4726-8.
63. Sledge GW Jr, Qulali M, Goulet R, Bone EA, Fife R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995;87:1546-50.
64. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, et al. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988;48:3307-12.
65. Naito K, Kanbayashi N, Nakajima S, Murai T, Arakawa K, Nishimura S, et al. Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer 1994;58:730-5.
66. Anderson IC, Shipp MA, Docherty AJ, Teicher BA. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 1996;56: 715-8.
67. r. 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 1990;50:3872-7.
68. Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A 1994;91:4293-7.
69. Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996;56:5279-84.
70. Kawamata H, Kameyama S, Kawai K, Tanaka Y, Nan L, Barch DH, et al. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A. Int J Cancer 1995;63:568-75.
71. Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, et al. Expression of membrane-type matrix metalloproteinase 1 (MTI-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 1996;56:5678-83.
72. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, et al. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 1993;53:417-22.
73. Albini A, Melchiori A, Sami L, Liotta LA, Brown PD, Stetler-Stevenson WG. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991; 83:775-9.
74. DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 1991;51:2151-7.
75. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
76. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 1992; 84:1017-22.
77. Alexander CM, Werb Z. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol 1992;118:727-39.
78. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, et al. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 1995;87:293-8.
79. Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor E, Hendrix M. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991;302:157-62.
80. Witty JP, McDonnell S, Newell K, Cannon P., Navre M, Tressler R, et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994;54:4805-12.
81. Noel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Mareel M, et al. Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest 1996;97:1924-30.
82. Chambers AF, Schmidt EE, MacDonald IC, Morris VL, Groom AC. Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. J Natl Cancer Inst 1992;84:797-803.
83. Chambers AF, MacDonald IC, Schmidt EE, Koop S, Morris VL, Khokha R, et al. Steps in tumor metastasis: new concepts from intravital videomicroscops. Cancer Metastasis Rev 1995;14:279-301.
84. MacDonald IC, Schmidt EE, Morris VL, Groom AC. Chambers AK. In vivo videomicroscopy of experimental hematogenous metastasis: Cancer cell arrest, extravasation and migration. In: Soll DR. editor. Motion analysis of living cells. New York: John Wiley & Sons. In press.
85. Morris VL, MacDonald IC, Koop S, Schmidt EE, Chambers AF, Groom AC. Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis 1993;11:377-90.
86. Koop S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, et al. Fate of melanoma cells entering the microcirculation: over 80% survive and extravasatc. Cancer Res 1995;55:2520-3.
87. Morris VL, Koop S, MacDonald IC, Schmidt EE, Grattan M, Percy D, et al. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation hut in subsequent migration and growth. Clin Exp Metastasis 1994;12:357-67.
88. Koop S, Schmidt EE, MacDonald IC, Morris VL, Khokha R, Grattan M, et al. Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A 1996;93:11080-4.
89. Khokha R, Zimmer MJ, Wilson SM, Chambers AF. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992;10:365-70.
90. Sethi N, Brookes M. Ultrastructure of the blood vessels in the chick allantois and chorioallantois. J Anat 1971;109:1-15.
91. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, et al. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994; 54:4791-7.
92. Martin DC, Ruther U, Sanchez-Sweatman OH, Orr FW, Khokha R. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene 1996;13:569-76.
93. Soloway PD, Alexander CM, Werb Z, Jaenisch R. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene 1996;13: 2307-14.
94. Imren S, Kohn DB, Shimada H, Blavier L, DeClerck YA. Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 1996;56:2891-5.
95. Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 1994;54:5467-73.
96. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 1991;97:679-85.
97. Nemeth JA, Goolsby CL. TIMP-2. a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp Cell Res 1993;207:376-82.
98. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994;107(Pt 9):2373-9.
99. Nemeth JA, Rafe A, Steiner M, Goolsby CL. TIMP-2 growth-stimulatory activity: a concentration-and cell type-specific response in the presence of insulin. Exp Cell Res 1996;224:110-5.
100. Stetler-Stevenson WG, Bersch N, Golde DW. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Leu 1992;296:231-4.
101. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318:66-9.
102. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985;315:768-71.
103. Chesler L, Golde DW, Bersch N, Johnson MD. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 1995;86:4506-15.
104. Sun Y, Kim H, Parker M, Stetler-Stevenson WG, Colburn NH. Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells: identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res 1996;16:1-7.
105. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts [published erratum appears in Cancer Res 1493;53:3652]. Cancer Res 1993;53: 2087-91.
106. Conway JG, Trexler SJ, Wakefield JA, Marron BE, Emerson DL, Bickett DM, et al. Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis Clin Exp Metastasis 1996:14:115-24.
107. Moses MA, Langer R. A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 1991;47:230-5.
108. Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N. Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994;160:194-202.
109. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L -tryptophan methyl-amide. Cancer Res 1994;54:4715-8.
110. Basset P, Bellocq JP, Wolf C, Stoll I. Hutin P. Limacher JM, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
111. D'Armiento J, DiColandrea T, Dalal SS, Okada Y, Huang MT, Conney AH, et al. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 1995;15:5732-9.
112. Sympson CJ, Bissell MJ, Werb Z. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Semin Cancer Biol 1995; 6:159-63.
113. Witty JP, Lempka T, Coffey RJ Jr, Matrisian LM. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 1995;55:1401-6.
114. Newell KJ, Witty JP, Rodgers WH, Matrisian LM. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994;10:199-206.
115. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996;149:273-82.
116. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A 1997;94:1402-7.
117. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992;267:17321-6.
118. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR, Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994;269:9352-60.
119. Silbiger SM, Jacobsen VL, Cupples RL, Koski RA. Cloning of cDNAs encoding human TIMP-3, a novel memher of the tissue inhibitor of metalloproteinase family. Gene 1994;141:293-7.
120. Wilde CG, Hawkins PR, Coleman RT, Levine VVB, Delegeane AM, Okamolo PM, et al. Cloning and characterizsation of human tissue inhibitor of metalloproteinases-3. DNA Cell Biol 1994;13:711-8.
121. Uria JA, Ferrando AA. Velasco G, Freijo JM, Lopez-Otin C. Structure and expression in breast tumors of human TIMP-3. a new member of the metalloproteinase inhibitor family. Cancer Res 1994;54:2091-4.
122. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375-80.
123. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J Biol Chem 1995;270:5872-6.
124. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996;56:944-9.
125. Cossins J, Dudgeon TJ, Catlin G, Gearing AJ, Clements JM. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 1996;228:494-8.
126. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51.
127. Pendas AM, Knauper V, Puenta XS, Llano E, Mattel MG, Apte S, et al. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997;272:4281-6.